ihaveDepression.com
Credits
and citations
1.
Altshuler LL, Hendrich V, Cohen LS. Course of mood and anxiety disorders
during pregnancy and the postpartum period. Journal of Clinical Psychiatry,
1998; 59: 29.
2.
Rohan KJ, Lindsey KT, Roecklein KA, Lacy TJ. Cognitive-behavioral therapy,
light therapy and their combination in treating seasonal affective disorder.
Journal of Affective Disorders, 2004; 80: 273-283.
3.
Regier DA, Rae DS, Narrow WE, Kaebler CT, Schatzberg AF. Prevalence of
anxiety disorders and their comorbidity with mood and addictive disorders.
British Journal of Psychiatry, 1998; 173 (Suppl. 34): 24-28.
4.
Devane CL, Chiao E, Franklin M, Kruep EJ. Anxiety disorders in the 21st
century: status, challenges, opportunities, and comorbidity with depression.
American Journal of Managed Care, 2005 Oct; 11(Suppl. 12): S344-353.
5.
Shalev AY, Freedman S, Perry T, Brandes D, Sahar T, Orr SP, Pitman RK.
Prospective study of posttraumatic stress disorder and depression following
trauma. American Journal of Psychiatry, 1998; 155(5): 630-637.
6.
Conway KP, ComptonW, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV
mood and anxiety disorders and specific drug use disorders: results from
the National Epidemiologic Survey on Alcohol and Related Conditions. Journal
of Clinical Psychiatry, 2006 Feb; 67(2): 247-257.
7.
Cassano P, Fava M. Depression and public health, an overview. Journal
of Psychosomatic Research, 2002; 53: 849-857.
8.
Katon W, Ciechanowski P. Impact of major depression on chronic medical
illness. Journal of Psychosomatic Research, 2002; 53: 859-863.
9.
Tsuang MT, Faraone SV. The genetics of mood disorders. Baltimore, MD:
Johns Hopkins University Press, 1990.
10.
Tsuang MT, Bar JL, Stone WS, Faraone SV. Gene-environment interactions
in mental disorders. World Psychiatry, 2004 June; 3(2): 73-83.
11.
Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications
for affective regulation. Biological Psychiatry, 1998; 44(9):
839-850.
12.
Pollack W. Mourning, melancholia and masculinity: recognizing and treating
depression in men. In: Pollack W, Levant R, eds. New Psychotherapy
for Men. New York: Wiley, 1998; 147-166.
13.
Cochran SV, Rabinowitz FE. Men and Depression: clinical and empirical
perspectives. San Diego: Academic Press, 2000.
14.
Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002.
National Vital Statistics Reports; 53(5). Hyattsville, MD: National
Center for Health Statistics, 2004.
15.
Gallo JJ, Rabins PV. Depression without sadness: alternative presentations
of depression in late life. American Family Physician, 1999;
60(3): 820-826.
16.
Krishnan KRR, Taylor WD, et al. Clinical characteristics of magnetic resonance
imaging-defined subcortical ischemic depression. Biological Psychiatry,
2004; 55: 390-397.
17.
Conwell Y. Suicide in later life: a review and recommendations for prevention.
Suicide and Life Threatening Behavior, 2001; 31(Suppl.): 32-47.
18.
Little JT, Reynolds CF III, Dew MA, Frank E, Begley AE, Miller MD, Cornes
C, Mazumdar S, Perel JM, Kupfer DJ. How common is resistance to treatment
in recurrent, nonpsychotic geriatric depression? American Journal
of Psychiatry, 1998; 155(8): 1035-1038.
19.
Reynolds CF III, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar
S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ. Nortriptyline and
interpersonal psychotherapy as maintenance therapies for recurrent major
depression: a randomized controlled trial in patients older than 59 years.
Journal of the American Medical Association, 1999; 281(1): 39-45.
20.
Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF, Alexopoulos GS, Bruce
MI, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey J, Niederehe G,
Parmelee P. Diagnosis and treatment of depression in late life: consensus
statement update. Journal of the American Medical Association,
1997; 278(14): 1186-1190.
21.
Reynolds CF III, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck
PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers
A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ. Maintenance treatment
of major depression in old age. New England Journal of Medicine,
2006 Mar 16; 354(11): 1130-1138.
22.
Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, Greenwald S, Klier
CM, Ryan ND, Dahl RE, Wichramaratne P. Depressed adolescents grown up.
Journal of the American Medical Association, 1999; 281(18): 1701-1713.
23.
Cyranowski JM, Frank E, Young E, Shear MK. Adolescent onset of the gender
difference in lifetime rates of major depression. Archives of General
Psychiatry, 2000; 57: 21-27.
24.
Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory
M. Psychiatric diagnosis in child and adolescent suicide. Archives
of General Psychiatry, 1996; 53(4): 339-348.
25.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino
M, McNulty S, Vitiello B, Severe J. Treatment for Adolescents with Depression
Study (TADS) team. Fluoxetine, cognitive-behavioral therapy, and their
combination for adolescents with depression: Treatment for Adolescents
with Depression Study (TADS) randomized controlled trial. Journal
of the American Medical Association, 2004; 292(7): 807-820.
26.
Rush JA, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME,
Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava
M. Bupropion-SR, Sertraline, or Venlafaxine-XR after failure of SSRIs
for depression. New England Journal of Medicine, 2006 Mar 23;
354(12): 1231-1242.
27.
Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz
L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush
JA. Medication augmentation after the failure of SSRIs for depression.
New England Journal of Medicine, 2006 Mar 23; 354(12): 1243-1252.
28.
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren
L, Brent DA. Clinical response and risk for reported suicidal ideation
and suicide attempts in pediatric antidepressant treatment, a meta-analysis
of randomized controlled trials. Journal of the American Medical Association,
2007; 297(15): 1683-1696.
29.
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum
(St. John's wort) in major depressive disorder: a randomized controlled
trial. Journal of the American Medical Association, 2002; 287(14):
1807-1814.
30.
Rami L, Bernardo M, Boget T, Ferrer J, Portella M, Gil-Verona JA, Salamero
M. Cognitive status of psychiatric patients under maintenance electroconvulsive
therapy: a one-year longitudinal study. The Journal of Neuropsychiatry and Clinical Neurosciences, 2004; 16: 465-471.
If you are looking for other websites that touch on health issues, check
these out:
|